China conditionally approves 2 COVIDQQ19 vaccines

China approved the registration applications of two domestically developed COVID-19 vaccines with conditions, the National Medical Products Administration said Thursday.

The administration also conditionally approved the recombinant vaccine for COVID-19 made by CanSino Biologics. It marked the first approved adenoviral vector vaccine for COVID-19.

An inactivated vaccine from the Wuhan Institute of Biological Products, an affiliate of China National Biotec Group of Sinopharm, was allowed to enter the market on a conditional basis, the administration said.

Photo/Shetuwang立博 app